<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>61(22)</volume><submitter>Di Girolamo A</submitter><funding>Consiglio Nazionale delle Ricerche</funding><funding>Universit? di Bologna</funding><pubmed_abstract>Five cationic iridium(III) complexes (&lt;b>1&lt;/b>-&lt;b>5&lt;/b>) were synthesized exploiting two triazole-based cyclometalating ligands, namely, 1-methyl-4-phenyl-1&lt;i>H&lt;/i>-1,2,3-triazole (&lt;b>A&lt;/b>) and the corresponding mesoionic carbene 1,3-dimethyl-4-phenyl-1&lt;i>H&lt;/i>-1,2,3-triazol-5-ylidene (&lt;b>B&lt;/b>). From the combination of these two ligands and the ancillary one, i.e., 4,4'-di-&lt;i>tert&lt;/i>-butyl-2,2'-bipyridine (for &lt;b>1&lt;/b>-&lt;b>3&lt;/b>) or &lt;i>tert&lt;/i>-butyl isocyanide (for &lt;b>4&lt;/b> and &lt;b>5&lt;/b>), not only the typical bis-heteroleptic complexes but also the much less explored tris-heteroleptic analogues (&lt;b>2&lt;/b> and &lt;b>5&lt;/b>) could be synthesized. The redox and emission properties of all of the complexes are effectively fine-tuned by the different ligands: (i) cyclometalating ligand &lt;b>A&lt;/b> in</pubmed_abstract><journal>Inorganic chemistry</journal><pagination>8509-8520</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9490865</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>4-Phenyl-1,2,3-triazoles as Versatile Ligands for Cationic Cyclometalated Iridium(III) Complexes.</pubmed_title><pmcid>PMC9490865</pmcid><pubmed_authors>Mazzanti A</pubmed_authors><pubmed_authors>Baschieri A</pubmed_authors><pubmed_authors>Monti F</pubmed_authors><pubmed_authors>Matteucci E</pubmed_authors><pubmed_authors>Di Girolamo A</pubmed_authors><pubmed_authors>Armaroli N</pubmed_authors><pubmed_authors>Sambri L</pubmed_authors></additional><is_claimable>false</is_claimable><name>4-Phenyl-1,2,3-triazoles as Versatile Ligands for Cationic Cyclometalated Iridium(III) Complexes.</name><description>Five cationic iridium(III) complexes (&lt;b>1&lt;/b>-&lt;b>5&lt;/b>) were synthesized exploiting two triazole-based cyclometalating ligands, namely, 1-methyl-4-phenyl-1&lt;i>H&lt;/i>-1,2,3-triazole (&lt;b>A&lt;/b>) and the corresponding mesoionic carbene 1,3-dimethyl-4-phenyl-1&lt;i>H&lt;/i>-1,2,3-triazol-5-ylidene (&lt;b>B&lt;/b>). From the combination of these two ligands and the ancillary one, i.e., 4,4'-di-&lt;i>tert&lt;/i>-butyl-2,2'-bipyridine (for &lt;b>1&lt;/b>-&lt;b>3&lt;/b>) or &lt;i>tert&lt;/i>-butyl isocyanide (for &lt;b>4&lt;/b> and &lt;b>5&lt;/b>), not only the typical bis-heteroleptic complexes but also the much less explored tris-heteroleptic analogues (&lt;b>2&lt;/b> and &lt;b>5&lt;/b>) could be synthesized. The redox and emission properties of all of the complexes are effectively fine-tuned by the different ligands: (i) cyclometalating ligand &lt;b>A&lt;/b> in</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Jun</publication><modification>2025-04-25T19:13:21.395Z</modification><creation>2025-04-06T07:50:49.255Z</creation></dates><accession>S-EPMC9490865</accession><cross_references><pubmed>35609179</pubmed><doi>10.1021/acs.inorgchem.2c00567</doi></cross_references></HashMap>